Study finds novel COVID-19 antibody therapy may reduce hospitalisations
The antibody slows down the replication process, allowing the patient's own immune system time to kick into gear
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
LY-CoV555
Eli Lilly pauses trial of antibody drug for COVID-19 over safety concern
The company had said earlier this month that it was applying for EUA for the antibody-drug, LY-CoV555, for patients with mild to…